The initial flare or enlargement of measurable areas of the tumor or the appearance of new lesions after the start of immunotherapy is known as pseudoprogression [12] - novel gene encoding with different concentrations of MMP inhibitor

The initial flare or enlargement of measurable areas of the tumor or the appearance of new lesions after the start of immunotherapy is known as pseudoprogression [12]. tumor and blood tissues revealed an homozygous c.1883G A mutation consistent with CMMRD. Given her CMMRD status, she was treated with nivolumab (3 mg/kg doses every 2 weeks … Continue reading The initial flare or enlargement of measurable areas of the tumor or the appearance of new lesions after the start of immunotherapy is known as pseudoprogression [12]